SH2D2A and neoplasm: However TCR transgenic SH2D2A-deficient peripheral CD4+ T cells in tumor mice displayed higher CD69 surface expression compared to mice without tumor (p = 0.05) or unchallenged mice (p<0,007) (Figure 7D).